Despite their ubiquitous use for rendering patients unconscious for surgery, our understanding of how general anesthetics cause hypnosis remains rudimentary at best. Recent years have seen increased interest in "top-down" cortico-centric theories of anesthetic action. The aim of this study was to explore this by investigating direct cortical effects of anesthetics on cerebrocortical evoked potentials in isolated mouse brain slices. Evoked potentials were elicited in cortical layer IV by electrical stimulation of the underlying white matter. The effects of three anesthetics (ketamine, etomidate, and isofl urane) on the amplitude, latency, and slope of short-latency evoked potentials were quantified. The N2/P3/N4 potentials -which represent the early cortical response -were enhanced by etomidate (increased P3-N4 slope, P <0.01), maintained by ketamine, and reduced by isoflurane (lower N2/P3 amplitude, P <0.01). These effects closely resemble those seen in vivo for the same drugs and point to a cortical mechanism independent of effects on subcortical structures such as the thalamus.
INTRODUCTION
W h e t h e r g e n e r a l a n e s t h e t i c s p r i n c i p a l l y a ff e c t cerebrocortical or subcortical structures to induce hypnosis is a matter of ongoing debate and speculation. The "thalamic gate" theory proposes that unconsciousness occurs when anesthetics deactivate the thalamus, preventing sensory information from reaching the cortex [1] .
This is the so-called "bottom-up" theory of anesthetic action. Studies on the effect of anesthetics on sensoryevoked potentials have given some credence to this theory, showing that the morphology of the early cortical evoked potentials (reflecting primary cortical responses to sensory input) is often altered during anesthesia [2, 3] .
A subcortical basis is further supported by the apparent mechanistic overlap between anesthesia and natural sleep, which is thought to be driven largely by brainstem arousal mechanisms [4] . However, there are exceptions that call into question the thalamic gate explanation as a unifying mechanism. Most notable is ketamine, which not only preserves sensory transmission to the cortex [5] , but may even enhance cortical responsiveness to incoming sensory information [6] and maintains an activated EEG.
Alternative explanations that accommodate anomalies such as ketamine invoke the cerebral cortex as the primary site of anesthetic action -the so-called "top-down" theories.
Top-down cortico-centric proposals are based on the idea that anesthetics disrupt the cortical processing of incoming sensory information [7] [8] [9] [10] , particularly impairing its capacity to represent complex information and/or integrate information across distributed cortical regions [11] .
The isolated cerebrocortical slice preparation provides an ideal model for testing the direct effects of anesthetic drugs on the cerebral cortex. In particular, somatosensory and visual cortical evoked potentials closely resembling those obtained in vivo [12] can be generated in isolated cortical slices by directly stimulating the subcortical white matter [13, 14] , without any influence from the thalamus and other subcortical structures.
White matter stimulation in the slice taps into reciprocal efferent and afferent thalamocortical pathways [13] from excitatory layer IV cortical neurons, from which classic sensory-evoked potentials can be readily recorded [15] .
Accordingly, the in vitro slice preparation is a useful model for investigating and interpreting the mechanisms of in vivo evoked potentials [13, 14] . In this study, we took advantage of this to investigate the direct effects of general anesthetics on cortical evoked potentials. In keeping with the cortico-centric theories of anesthetic action, a recent study showed that the suppression of auditory evoked potentials by isoflurane is primarily through its direct effects on intracortical pathways [10] . The aim of this study was to expand these findings to include anesthetics with diverse molecular mechanisms of action, namely ketamine (primarily an N-methyl-D-aspartate antagonist) and etomidate (primarily a type-A γ-aminobutyric acid agonist).
MATERIALS AND METHODS

Slice Preparation
The animal procedures were approved by the Waikato Animal Ethics Committee. Coronal brain slices (400 μm)
were prepared between bregma -2 to -5 mm from adult wild-type mice (C57 and 129SV) following CO 2 anesthesia. were maintained submerged at room temperature (20-22°C).
Recording Parameters
The slices were stimulated with constant-current 100 μs square-wave pulses delivered at 0. The evoked responses are reported without averaging unless otherwise stated.
Experimental Protocols
Three anesthetics were tested, ketamine (16 μmol/L, 10 slices from 3 animals), etomidate (24 μmol/L, 11 slices from 6 animals) and isofl urane (1 minimum alveolar concentration (MAC) equivalent, 9 slices from 3 animals). In the etomidate and ketamine experiments, the recording bath was perfused using a passive gravity-feed method, with the appropriate amount of each drug added directly to the pre-carbogenated perfusate. Isoflurane could not be delivered using this method because of its volatility and was instead perfused via syringe-pump at 5 mL/min (see details below).
In each trial, a baseline of at least 10 min was 
Determination of Isofl urane Concentration
In pilot experiments, we determined that adding 0.01 mL isoflurane to 50 mL of pre-carbogenated aCSF in a sealed syringe, perfused via syringe pump at 5 mL/min, generated a slice bath isofl urane concentration very close to 1 rat MAC. This was confi rmed using two methods. First, following the above perfusion regime, bath aCSF samples were extracted and isofl urane concentration measured every 4 min during a 20-min perfusion period using HPLC analysis.
The isoflurane levels peaked after ~8 min and remained stable throughout the perfusion period, during which the average concentration was 480 μmol/L, ~1 rat MAC [16] [17] [18] .
Second, using the same perfusion protocol, the headspace above the perfusion bath was sealed and the headspace gas above the bath was recirculated through an S5 entropy monitor (Planar Systems Inc., Beaverton, USA). The volume percent of isoflurane in the headspace reached a stable equilibrium value of 1.2% after ~10 min. Furthermore, the anticonvulsant effect of isofl urane at this dose on neocortical slice seizures is known to be equivalent to that for 1 rat MAC of isofl urane [17] , confi rming the dose calculation.
Data Analysis
Individual evoked potentials were analyzed according to the scheme shown in Figure 1 . The P3 wave was used as the basis for analysis because the P1 wave was either not always present or could not be reliably resolved from the stimulus artefact. The amplitude and latency of the P3 wave was derived from the voltage and time differences from the N2 trough to the P3 peak. The P3-N4 slope was calculated as the maximum slope between the P3 peak and the N4 trough. That is, the voltage differential was calculated for all sequential data-points between the P3 peak and N4 trough and the maximum negative differential was recorded as the maximum slope for that evoked response. Each parameter was then averaged within the time windows specified above, giving "baseline", "drug", and "washout" periods for statistical analysis. The three periods were compared for each agent using the non-parametric Friedman test for repeated measures ANOVA. The percentage change in each parameter ("baseline" versus "drug") was also compared across agents using the Kruskal-Wallis test.
Results are presented as mean (SEM) and a P-value <0.05 was considered statistically signifi cant.
RESULTS AND DISCUSSION
The effects of each intervention on P3 amplitude, P3
latency, and P3-N4 slope are summarized in Figure 2 . 
Control Findings
In the control experiments, subtle but signifi cant time effects were seen as increases in the P3-N4 slope (140 μV/ms versus 119 μV/ms, P <0.01) and P3 amplitude (119 μV vs 105 μV, P <0.05) during the washout period. The P3 latency also trended downward in the control slices (P = 0.052).
Anesthetic Findings
These changes in the control group were closely mirrored in the ketamine group, suggesting a negligible drug effect in this case. That is, the P3-N4 slope increased (135 μV/ ms vs 128 μV/ms, P <0.05), as did P3 amplitude (297 μV vs 275 μV, P <0.05). A time trend in the P3-N4 slope also appeared to book-end the etomidate experiments ( Isoflurane also reduced the P3 latency, which was again most evident during washout (2.9 ms vs 3.1 ms, P <0.01). 
Effect of aCSF Perfusion Rate
When changing aCSF solutions (for drug delivery and/ or washout), small perturbations to the aCSF delivery characteristics can occur, resulting in slight changes in the fl ow rate and/or fl uid level in the bath. To rule out the possibility that this could account for the drug-correlated changes in P3-N4 slope, we tested the effect of deliberately altering each on the evoked response. The slope index was robust against such effects, even with a 3-fold change in fl ow rate, which far exceeded that occurring in this study (Fig. 3) .
Results from In Vivo Studies
The aim of this study was to investigate whether the anesthetic effects on evoked potentials in vivo, which are generally attributed to a "bottom-up" subcortical (thalamic) mechanism, could be reproduced in isolated cortical slices, thereby implicating a "top-down" cerebrocortical action. In vivo studies have shown that primary somatosensory and auditory cortical sensory evoked potentials are variably affected by anesthetics. For example, the amplitude of the N20-P23 wave (representing the early primary cortical response) is consistently increased during etomidate anesthesia [2, 19] . Evoked potential slope is not typically measured in clinical studies; however, an increase in population event amplitude is usually accompanied by an increase in event slope. Clinical studies have shown mixed results for ketamine, with either maintenance [5] or enhancement [20] of N20-P23 amplitude. The effects of etomidate and ketamine contrast with the volatile anesthetics, tending to reduce the amplitude and increase the latency of cortical evoked responses [3, 21] .
Comparison with In Vitro Data from This Study
The cortical slice findings in our study largely paralleled the above in vivo data. Etomidate enhanced the cortical evoked response, seen as an increase in the P3-N4 slope.
While the group analysis of P3 amplitude did not reveal a significant etomidate effect, a number of individual slices exhibited strong increases in P3 amplitude corresponding to the period of drug delivery (Fig. 4) -an effect not observed during perfusion with the other anesthetics tested.
Similar to the clinical studies, ketamine also increased the P3 amplitude and P3-N4 slope, but to a lesser degree.
While both effects could be attributed to an effect of time,
at the very least we can conclude that ketamine maintained the evoked potential morphology in the slice model.
Isoflurane was the only anesthetic tested that caused a reduction in P3 amplitude. Together, these fi ndings suggest that anesthetic effects on cortical evoked potentials are due largely to top-down cortical effects, supporting the corticocentric view of anesthetic action.
Mechanistic Considerations for Anesthetic Hypnosis
We would point out that our study does not provide direct across distributed cortical regions [9, 11] . 
Anesthetic Dosage
Without directly quantifying the drug levels in slice tissue, there is no absolutely reliable method to ensure equipotent, clinically relevant hypnotic dosing of anesthetic drugs in slices. Our choice of dosage regimens for etomidate and ketamine was based largely on the known diffusion characteristics of etomidate into cortical slice tissue. When recording from the middle of a 400-μm slice, the etomidate concentration reaches only 17%-50% of its aCSF level after 10-min perfusion at a constant aCSF concentration [22] .
The perfusion system and protocol we used achieved a constant aCSF etomidate concentration in the bath of 6 μg/ mL for ~10 min (data not shown), which would achieve a tissue concentration of ~1-3 μg/mL. In reality, the maximum concentration reaching the tissue would have been slightly higher than this, taking into account the drug wash-in and wash-out periods. Deep anesthesia with etomidate requires an effect site concentration of ~3.3 μg/mL in rodents [23] . Thus, the etomidate perfusion regime we used probably delivered the equivalent of a deep hypnotic dose.
Because there are no experimental data on the diffusion of ketamine in cortical slices, a concentration of 4 μg/mL was chosen based on the relative clinical hypnotic potencies of ketamine and etomidate.
Data Consistency and Exclusions
It is evident from Figure 1 that evoked potential morphology varies somewhat from one preparation to another. This is probably due to small variations in recording electrode placement [13] . Despite the variant waveform shapes, the P3-N4 complex previously described [13] was clearly discernable in all but 3 cases. These recordings (2 etomidate and 1 control) were excluded from the analysis. Two further recordings were excluded due to preparation disturbances that prevented completion of the experimental protocol.
Conclusion
We conclude that the effects of three different categories of general anesthetic drugs on primary evoked potentials in isolated cortical slices closely replicate the effects of these drugs seen in clinical somatosensory evoked potential studies. This suggests that the anesthetic effects on evoked potential morphology are largely independent of any actions on subcortical structures.
